Latest News and Press Releases

PolTREG and U.S. Subsidiary Immuthera Secure Positive FDA Opinion, Paving the Way for a Registrational Pre-Symptomatic Type 1 Diabetes Trial FDA agreed that PolTREG’s clinical data in Stage 3...

New 1,200 m² facility in Aachen expands headquarters to support company growth and scale Human Platelet Lysate productionSite provides the world’s largest HPL output with 20,000L annual capacity and a...

HOUSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for...

HOUSTON, July 28, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the...

Dublin, July 24, 2025 (GLOBE NEWSWIRE) -- The "CAR T-Cell Therapy Market Size, Growth, Share, Trends and Forecasts 2025-2033" report has been added to ResearchAndMarkets.com's offering. The...

AGT103-T shows HIV reservoir reduction in all patients; one to undetectable. AGT unveils functional cure data at IAS 2025 late-breaker.

SINGAPORE, July 21, 2025 (GLOBE NEWSWIRE) -- Further to our announcement filed on Form 6-K on November 20, 2024, CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based...

Longeveron licenses patented stem cell technology from the University of Miami.

Dublin, July 16, 2025 (GLOBE NEWSWIRE) -- The "Regenerative Medicine Market by Product and Application - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading...

Tevogen.AI’s model drastically reduces target analysis and has the potential to generate billions in cost savings across the healthcare system by streamlining early-stage drug discovery, reducing wet...